New evidence to reconcile in vitro and epidemiologic data on the possible role of heroin on CD4+ decline among HIV-infected injecting drug users

Drug Alcohol Depend. 1999 Apr 1;54(2):145-54. doi: 10.1016/s0376-8716(98)00158-6.

Abstract

Long-term effects of drug type and other drug use related risk factors on CD4+ cell decline were assessed in 224 HIV-infected injecting drug users (IDUs) from Baltimore (ALIVE), USA, and 63 IDUs from Amsterdam, The Netherlands. Higher frequencies of borrowing used injection equipment since 1980 resulted in a higher CD4+ count already present before seroconversion (P = 0.049). Use of mainly heroin in the seroconversion interval resulted in a sharper CD4+ decline until the first 6 months after seroconversion (P = 0.004), but CD4+ values converged later on. This finding might reconcile earlier discordant epidemiological and laboratory study results regarding the possible effects of heroin.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Baltimore / epidemiology
  • CD4-Positive T-Lymphocytes / drug effects*
  • Cocaine / adverse effects
  • Cohort Studies
  • Comorbidity
  • Confounding Factors, Epidemiologic
  • Disease Progression
  • Female
  • HIV Infections / epidemiology
  • HIV Infections / immunology*
  • Heroin / adverse effects
  • Humans
  • Immunocompetence / drug effects
  • Linear Models
  • Lymphocyte Count / drug effects
  • Male
  • Netherlands / epidemiology
  • Risk Factors
  • Substance Abuse, Intravenous / epidemiology
  • Substance Abuse, Intravenous / immunology*

Substances

  • Heroin
  • Cocaine